Professor Jude Fitzgibbon

Professor Fitzgibbon received his BA degree in Genetics from Trinity College Dublin in 1989 before completing a PhD studies at University College London in 1993, on the genetics of Tuberous Sclerosis. He has worked in the Centre for Haemato-Oncology in the Barts Cancer Institute in London since 1997 focussing on the molecular pathogenesis of both leukaemia and lymphomas. He currently receives programme grant funding from Cancer Research UK (Personalised Epigenetic Therapy for Follicular Lymphoma and Improving outcome for patients with poor risk Acute Myeloid Leukaemia) and Bloodwise (The genetics of familial leukaemia) and is a member of the UK Precision Medicine in Aggressive Lymphoma (PMAL) consortium and the NCRI Clinical Studies Group in Lymphoma.